Drawing for LONZOR

USPTO serial 87404854

LONZOR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
WHITE, RICHARD F
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LONZOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthmaABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2022MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Jun 27, 2022ABN4ABANDONMENT - AFTER INTER PARTES DECISION
Jun 27, 2022OP.TOPPOSITION TERMINATED NO. 999999
Jun 27, 2022OP.SOPPOSITION SUSTAINED NO. 999999
Jun 22, 2022OP.IOPPOSITION INSTITUTED NO. 999999
Jun 22, 2022OPPFOPPOSITION PAPERS RECEIVED AT TTAB
May 24, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 4, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 21, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 15, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 13, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 13, 2019ALIEASSIGNED TO LIE
Oct 30, 2019DOCKASSIGNED TO EXAMINER
May 13, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 13, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 10, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 27, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 27, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 27, 2017GNSLLETTER OF SUSPENSION E-MAILED
Apr 27, 2017CNSLSUSPENSION LETTER WRITTEN
Apr 27, 2017DOCKASSIGNED TO EXAMINER
Apr 15, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 13, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance